35 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
interviews, inquiry of the person or persons making the recommendation or nomination, engagement of an outside search firm to gather additional information …
The hiring, engagement and retention of a skilled workforce is particularly important in the highly competitive scientific fields in which we operate. Our
8-K
EX-10.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL … during such time); and (ii) the period (if any) during which Participant may exercise the Option after such termination of Participant’s engagement
8-K
EX-99.1
ATHA
Athira Pharma Inc
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
and continued engagement with U.S. Food and Drug Administration
Appointed Andrew Gengos as Chief Financial Officer and Chief Business Officer
Maintains
8-K
EX-99.1
ATHA
Athira Pharma Inc
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
started his career as a Technology Associate at Morgan Stanley before moving on to McKinsey & Co., where he advanced from associate to Senior Engagement
8-K
EX-3.1
rabgr3
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
DFAN14A
EX-99.1
y9wb4kiro4k lqe
12 May 22
Additional proxy materials by non-management
2:06pm
DFAN14A
EX-99.1
bnbzflqdqauc
27 Apr 22
Additional proxy materials by non-management
2:39pm
DEFC14A
a1njt8 ee
11 Apr 22
Proxy in contested solicitation
8:36am
PREC14A
gk6gr5ijo5
8 Apr 22
Preliminary proxy with contested solicitation
4:21pm
DEFA14A
ds6lx zl78
5 Apr 22
Additional proxy soliciting materials
5:03pm
DEFC14A
djbz xn3kg8oizkpayn5
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
unwav76xk 51
30 Mar 22
Preliminary proxy with contested solicitation
5:23pm
DFAN14A
38f b4fs2vncruxuc6y
30 Mar 22
Additional proxy materials by non-management
10:21am
PREC14A
70w m7qyls
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
DEF 14A
ei2r8an1hj2ooc
16 Apr 21
Definitive proxy
6:02am
10-K
7nt1qh
25 Mar 21
Annual report
12:00am
424B4
cm45t72
21 Jan 21
Prospectus supplement with pricing info
12:00am